NextPlat Q2 revenue up 21% sequentially to $11.9M; net loss down 87% to $144K

NextPlat Corp

Q2 revenue $11.9M, +21% sequentially; gross margin record 40% vs 35% prior quarter.
Net loss attributable to common stockholders $0.1M ($0.05/diluted share) vs $1.8M ($0.69) year ago.
Contracted pharmacy revenue up 136% YoY to $2.2M; e-commerce revenue $4.1M, +27% sequentially.
Cash $11.9M, working capital $14.2M, no material unsecured debt; 11 new contracted entities signed in H1.
Intends to acquire profitable pharmacy operation in Pensacola, FL; new nationwide medication fulfillment website expected Q3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.